7 insiders reported 41 Form 4 transactions for Protara Therapeutics, Inc. (TARA) over the past 18 months (most recent 2026-07-01). Recent activity: Shefferman Jesse (CEO and President) Buy 215,687 shares, Shefferman Jesse (CEO and President) Sell 215,687 shares, Shefferman Jesse (CEO and President) Sell 14,000 shares, Shefferman Jesse (CEO and President) Sell 7,000 shares, Shefferman Jesse (CEO and President) Sell 4,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-01 | Shefferman Jesse | CEO and President | Buy | 215,687 | $411,962 |
| 2026-07-01 | Shefferman Jesse | CEO and President | Sell | 215,687 | $882,160 |
| 2026-07-01 | Shefferman Jesse | CEO and President | Sell | 14,000 | $0 |
| 2026-07-01 | Shefferman Jesse | CEO and President | Sell | 7,000 | $0 |
| 2026-07-01 | Shefferman Jesse | CEO and President | Sell | 4,000 | $0 |
| 2026-07-01 | Shefferman Jesse | CEO and President | Sell | 5,000 | $0 |
| 2026-06-03 | CONKLING WILLIAM | Chief Commercial Officer | Sell | 6,008 | $26,075 |
| 2026-04-09 | Zummo Jacqueline | Chief R&D Officer | Sell | 1,134 | $6,124 |
| 2026-04-02 | Zummo Jacqueline | Chief R&D Officer | Sell | 22,598 | $118,865 |
| 2026-01-27 | Zummo Jacqueline | Chf Scientific Operations Off | Sell | 3,724 | $24,839 |
| 2026-01-27 | Shefferman Jesse | CEO and President | Sell | 8,732 | $58,242 |
| 2026-01-27 | Fabbio Patrick | Chief Financial Officer | Sell | 3,261 | $21,751 |
| 2026-01-27 | Fry Hannah | VP, Controller | Sell | 1,457 | $9,718 |
| 2026-01-22 | Zummo Jacqueline | Chf Scientific Operations Off | Sell | 6,578 | $36,837 |
| 2026-01-22 | Fabbio Patrick | Chief Financial Officer | Sell | 3,063 | $17,153 |
| 2026-01-22 | Fry Hannah | VP, Controller | Sell | 2,132 | $11,939 |
| 2026-01-22 | Shefferman Jesse | CEO and President | Sell | 16,322 | $91,403 |
| 2026-01-21 | Shefferman Jesse | CEO and President | Buy | 87,000 | $0 |
| 2026-01-21 | Zummo Jacqueline | Chf Scientific Operations Off | Buy | 30,000 | $0 |
| 2026-01-21 | Fabbio Patrick | Chief Financial Officer | Buy | 28,000 | $0 |
| 2026-01-21 | CONKLING WILLIAM | Chief Commercial Officer | Buy | 26,000 | $0 |
| 2026-01-21 | Nicacio Leonardo Viana | Chief Medical Officer | Buy | 26,000 | $0 |
| 2026-01-21 | Fry Hannah | VP, Controller | Buy | 9,500 | $0 |
| 2025-07-07 | Shefferman Jesse | CEO and President | Sell | 300,000 | $0 |
| 2025-06-30 | Shefferman Jesse | CEO and President | Sell | 1,700 | $0 |
Source: SEC Form 4 filings · as of 2026-07-01